Talgoy M M, Bell A W, Duckworth H W
Can J Biochem. 1979 Jun;57(6):822-33. doi: 10.1139/o79-102.
Citrate synthase of Escherichia coli reacts rapidly with 1 equivalent of Ellman's reagent, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), per subunit, losing completely its sensitivity to the allosteric inhibitor, NADH. When the enzyme is treated instead with 4,4'-dithiodipyridine (4,4'-PDS), all activity is lost. Certain evidence in this paper is consistent with the belief that the sulfhydryl group modified by DTNB, and that whose modification by 4,4'-PDS inactivates the enzyme, are the same. (i) Both reagents abolish NADH fluorescence enhancement by the enzyme. (ii) Saturating levels of NADH and some other adenylic acid derivatives inhibit the reactions with both reagents. (iii) When the enzyme is modified with one equivalent of DTNB or 4,4'-PDS, subsequent reactivity toward the other reagent is greatly decreased. (iv) Following modifications, the DTNB and 4,4'-PDS derivatives spontaneously lose thionitrobenzoate (TNB) or pyridine-4-thione (PT), respectively, in reactions which are thought to involve displacement of TNB or PT by a second enzyme sulfhydryl group, so that an enzyme disulfide is introduced. The introduction of the disulfide bond, if this is what occurs, does not lead to cross-linking of citrate synthase polypeptide chains, as judged by sodium dodecyl sulfate polyacrylamide gel electrophoresis under nonreducing conditions. Certain evidence has also been found, however, that the sites of modification by DTNB and 4,4'-PDS are not the same. (i) DTNB modification desensitizes to NADH but does not inactivate, while 4,4'-PDS inactivates at least 99.9%. (ii) The presumed disulfide from elimination of TNB is also active, while that from PT modification is no more active than the original 4,4'-PDS modified product. (iii) Prior modification of the enzyme with DTNB affords no protection against later inactivation by 4,4'-PDS. The studies therefore indicate a close relationship between the DTNB desensitization and 4,4'-PDS inactivation, but they are unable to identify it exactly. Other properties of the DTNB reaction are also described, and a hypothesis is offered to explain quantitatively the finding that desensitization lags behind modification during the modification of citrate synthase by DTNB.
大肠杆菌的柠檬酸合酶每个亚基能迅速与1当量的埃尔曼试剂5,5'-二硫代双(2-硝基苯甲酸)(DTNB)反应,完全丧失其对变构抑制剂NADH的敏感性。当用4,4'-二硫代二吡啶(4,4'-PDS)处理该酶时,所有活性均丧失。本文中的某些证据支持这样一种观点,即被DTNB修饰的巯基以及被4,4'-PDS修饰而使酶失活的巯基是同一个。(i)两种试剂都能消除酶引起的NADH荧光增强。(ii)饱和水平的NADH和其他一些腺苷酸衍生物会抑制与这两种试剂的反应。(iii)当用1当量的DTNB或4,4'-PDS修饰酶后,其对另一种试剂的后续反应性会大大降低。(iv)修饰后,DTNB和4,4'-PDS衍生物会分别自发地失去硫代硝基苯甲酸(TNB)或吡啶-4-硫酮(PT),这些反应被认为涉及第二个酶巯基取代TNB或PT,从而引入了一个酶二硫键。通过非还原条件下的十二烷基硫酸钠聚丙烯酰胺凝胶电泳判断,如果确实发生了二硫键的引入,这并不会导致柠檬酸合酶多肽链的交联。然而,也发现了某些证据表明DTNB和4,4'-PDS的修饰位点并不相同。(i)DTNB修饰使酶对NADH脱敏但不会使其失活,而4,4'-PDS至少能使99.9%的酶失活。(ii)从消除TNB得到的假定二硫键仍然具有活性,而从PT修饰得到的二硫键并不比原来的4,4'-PDS修饰产物更具活性。(iii)先用DTNB对酶进行修饰并不能保护其免受后来4,4'-PDS的失活作用。因此,这些研究表明DTNB脱敏和4,4'-PDS失活之间存在密切关系,但无法确切确定这种关系。还描述了DTNB反应的其他特性,并提出了一个假设,用于定量解释在DTNB修饰柠檬酸合酶过程中脱敏滞后于修饰这一发现。